Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001
Completed · Has a placebo group
Conditions studied: Fragile X Syndrome
In brief
The subjects that meet the inclusion and exclusion criteria and consent to participate in protocol 22001 will be offered participation in 22001A which will evaluate secreted protein before and after treatment with STX209 and placebo to determine if they correlate with effectiveness of treatment or susceptibility to treatment with STX209. These same subjects will also be asked to contribute a blood sample for DNA (deoxyribonucleic acid) collection. The investigators will study the DNA to determine if STX209 works better in people with specific gene variations, or to find new gene variations that predict how well STX209 works.
Key facts
- Study ID
- NCT00823368
- Run by
- Seaside Therapeutics, Inc.
- Starts
- 2009-01-01
- Last updated by the study team
- 2013-07-31
Who can join
Age: 6 and older, up to 40. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects that meet the inclusion and exclusion criteria and consent to participate in protocol 22001
You may not qualify if…
- Subjects that meet the inclusion and exclusion criteria and consent to participate in protocol 22001
Where it is running
- Southwest Autism Research & Resource Center — Phoenix, Arizona, United States
- University of California-Los Angeles Neuropsychiatric Institute — Los Angeles, California, United States
- M.I.N.D. Institute — Sacramento, California, United States
- Rush University Medical Center — Chicago, Illinois, United States
- Riley Hospital for Children — Indianapolis, Indiana, United States
- NYS Institute for Basic Research in Developmental Disabilities — Staten Island, New York, United States
- University of North Carolina Neurosciences Hospital — Chapel Hill, North Carolina, United States
- Suburban Research Associates — Media, Pennsylvania, United States
- Vanderbilt Kennedy Center — Nashville, Tennessee, United States
- Red Oaks Psychiatry Associates, PA — Houston, Texas, United States
- Seattle Children's Hospital — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.